Statistics (since 2007)

Status: Wednesday, 01. April 2026

14863 completed cases

Male patients 6984 47%
Female patients 7879 53%
Children and youths 3625 24%
Adults 11238 76%

completed cases per country:

Germany 10968 74%
Austria 1260 8%
Switzerland 2635 18%

2989 completed cases

Male patients 1614 54%
Female patients 1375 46%
Children and youths 1228 41%
Adults 1761 59%

3869 completed cases

Male patients 2157 56%
Female patients 1712 44%
Children and youths 1517 39%
Adults 2352 61%

completed cases per country:

Brazil 286 7%
Bulgaria 256 7%
Greece 444 11%
Ireland 252 7%
Italy 1058 27%
Poland 645 17%
Spain 715 18%
Romania 85 2%
Netherlands 92 2%
Croatia 36 1%

347 completed cases

Male patients 189 54%
Female patients 158 46%
Children and youths 305 88%
Adults 42 12%

Welcome

The Anaphylaxis Registry (NORA - Network for Online-Registration of Anaphylaxis) aims to collect data on severe allergic reactions. Since data collection began in 2007 across German-speaking countries, anaphylactic reactions have been continuously documented. Since 2011, NORA has been open internationally; since then, an average of around 1,300 cases per year have been recorded.
Overall, the most common triggers include insect venoms, foods, and medications—though their distribution differs between children (mainly foods) and adults (mainly insect venoms).
Anaphylaxis is a severe allergic reaction that can progress rapidly and may be fatal. An increase in anaphylactic reactions has been reported worldwide. Because anaphylactic reactions are not subject to mandatory reporting, there is no comprehensive official statistic on their frequency, course, and outcomes. In addition, modern life continually exposes people to new and sometimes unknown substances and environmental factors. Exotic foods, for example fruits, are imported from all over the world and consumed locally.
Within this project we aim to obtain information on triggers, cofactors, and treatment of patients who experienced a severe allergic reaction. Such data  will help to improve the knowledge and treatment modalities of affected patients.